Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
2024 ADJUSTED NET INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS AND ADJUSTED EARNINGS PER SHARE - DILUTED OUTLOOK
| |||||||
Fiscal Year 2024 | |||||||
Low | High | ||||||
Net income attributable to common stockholders | $ | 265 | $ | 300 | |||
Provision for income taxes | 119 | 134 | |||||
Income before income taxes attributable to common stockholders | 384 | 434 | |||||
Certain items(1) | 33 | 28 | |||||
Adjusted pretax income* | 417 | 462 | |||||
Provision for income taxes | (122 | ) | (137 | ) | |||
Adjusted net income attributable to common stockholders* | $ | 295 | $ | 325 | |||
Earnings per share - Diluted(2)(3) | $ | 6.74 | $ | 7.57 | |||
Adjusted earnings per share - Diluted(2)(3)* | $ | 7.45 | $ | 8.16 | |||
Diluted shares(2) | 42.1 | 42.1 |
2024 ADJUSTED EBITDA OUTLOOK
| |||||||
Fiscal Year 2024 | |||||||
Low | High | ||||||
Net income attributable to common stockholders | $ | 265 | $ | 300 | |||
Interest expense | 163 | 158 | |||||
Provision for income taxes | 119 | 134 | |||||
Depreciation and amortization | 143 | 143 | |||||
Share-based compensation | 37 | 37 | |||||
Certain items(1) | 33 | 28 | |||||
Adjusted EBITDA* | $ | 760 | $ | 800 |
(1) Certain items adjustment includes $15 million to $20 million of anticipated transaction and integration costs and $13 million of litigation and other charges. |
(2) Includes 6.8 million shares from the assumed conversion of our convertible notes. |
(3) Includes an add back of $19 million of interest expense related to our convertible notes, net of tax for purposes of calculating net income in the diluted earnings per share calculation. |
* Denotes non-GAAP financial measures. Please see "Non-GAAP Financial Measures" for additional information about our reasons for providing these alternative financial measures and limitations on their use. |
Posted In: VAC